FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017614587> ?p ?o ?g. }

• W2017614587 endingPage "678" @default.
• W2017614587 startingPage "671" @default.
• W2017614587 abstract "The relationship between blood pressure (BP) and cardiovascular morbidity has been appreciated for many years. Casual BP may not be repressentative of the pressure at other times. It is recognized that BP during exercise may be a more accurate predictor than casual BP. There is, however, little information about the effects of antihypertensive drugs on the BP during exercise. This study was designed to investigate the effects of various antihypertensive agents on BP during exercise. Sixty-four patients (age, 49±10 years) with untreated essential hypertension (WHO I, II) were studied during a supine ergometric exercise regimen. A graded exercise test was started at a workload of 50 W, and the load was increased by 25 W every 3 min. The hemodynamic responses to exercise were evaluated by changes in systolic and diastolic BP (SBP, DBP) and heart rate (HR). Plasma norepinephrine (NE) levels were measured at rest and during submaximal exercise, and before and after 4 weeks of treatment with metoprolol (METO), doxazosin (DOXA), trichlormethiazide (TCTZ), nifedipine (NIFE), amlodipine (AMLO) and temocapril (TEMO) between left ventricular mass index (LVMI) and BP values at rest, during exercise, and during the recovery period after exercise were assessed by multiple reguression analysis. The stepwise selection (forward conditional) method showed that LVMI was significantly associated with SBP during submaximal exercise and during the recovery period. All antihypertensive treatments decreased SBP and DBP (p<0.01) at rest. METO, AMLO and TEMO significantly lowered SBP (p<0.05) during exercise, whereas DOXA, TCTZ and NIFE induced no change in SBP. The exercise-induced increase of plasma NE was further enhanced by METO and NIFE but not by AMLO, DOXA, or TCTZ, and it was significantly suppressed by TEMO (p<0.01). There results suggest that BP during exercise is more highly associated with the progression of left ventricular hypertrophy (LVH) than is casual BP. Because antihypertensive agents differ in their effects on exercise hemodynamics, we recommend that hemodynamic factors during exercise be considered when selecting the optimal antihypertensive medication for highly active patients. (Hypertens Res 2001; 24: 671-678)" @default.
• W2017614587 created "2016-06-24" @default.
• W2017614587 creator A5012615978 @default.
• W2017614587 creator A5019186366 @default.
• W2017614587 creator A5019333020 @default.
• W2017614587 creator A5030494232 @default.
• W2017614587 creator A5054804668 @default.
• W2017614587 creator A5062980637 @default.
• W2017614587 creator A5071832747 @default.
• W2017614587 date "2001-01-01" @default.
• W2017614587 modified "2023-10-11" @default.
• W2017614587 title "Effects of Antihypertensive Agents on Blood Pressure during Exercise." @default.
• W2017614587 cites W1899108470 @default.
• W2017614587 cites W1968563590 @default.
• W2017614587 cites W1969411649 @default.
• W2017614587 cites W1969525676 @default.
• W2017614587 cites W1977574579 @default.
• W2017614587 cites W1986207908 @default.
• W2017614587 cites W1995790025 @default.
• W2017614587 cites W1995934832 @default.
• W2017614587 cites W1996606318 @default.
• W2017614587 cites W2003560001 @default.
• W2017614587 cites W2009416654 @default.
• W2017614587 cites W2011187155 @default.
• W2017614587 cites W2022960606 @default.
• W2017614587 cites W2031359251 @default.
• W2017614587 cites W2046684844 @default.
• W2017614587 cites W2050016566 @default.
• W2017614587 cites W2057233709 @default.
• W2017614587 cites W2069838044 @default.
• W2017614587 cites W2070448884 @default.
• W2017614587 cites W2076273586 @default.
• W2017614587 cites W2085021609 @default.
• W2017614587 cites W2092805838 @default.
• W2017614587 cites W2092869808 @default.
• W2017614587 cites W2245758337 @default.
• W2017614587 cites W2332606446 @default.
• W2017614587 cites W2400963859 @default.
• W2017614587 cites W4235430003 @default.
• W2017614587 cites W4251123683 @default.
• W2017614587 doi "https://doi.org/10.1291/hypres.24.671" @default.
• W2017614587 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11768726" @default.
• W2017614587 hasPublicationYear "2001" @default.
• W2017614587 type Work @default.
• W2017614587 sameAs 2017614587 @default.
• W2017614587 citedByCount "10" @default.
• W2017614587 countsByYear W20176145872013 @default.
• W2017614587 countsByYear W20176145872014 @default.
• W2017614587 countsByYear W20176145872018 @default.
• W2017614587 countsByYear W20176145872020 @default.
• W2017614587 countsByYear W20176145872022 @default.
• W2017614587 crossrefType "journal-article" @default.
• W2017614587 hasAuthorship W2017614587A5012615978 @default.
• W2017614587 hasAuthorship W2017614587A5019186366 @default.
• W2017614587 hasAuthorship W2017614587A5019333020 @default.
• W2017614587 hasAuthorship W2017614587A5030494232 @default.
• W2017614587 hasAuthorship W2017614587A5054804668 @default.
• W2017614587 hasAuthorship W2017614587A5062980637 @default.
• W2017614587 hasAuthorship W2017614587A5071832747 @default.
• W2017614587 hasBestOaLocation W20176145871 @default.
• W2017614587 hasConcept C126322002 @default.
• W2017614587 hasConcept C164705383 @default.
• W2017614587 hasConcept C178853913 @default.
• W2017614587 hasConcept C2777097880 @default.
• W2017614587 hasConcept C2777953023 @default.
• W2017614587 hasConcept C2779066535 @default.
• W2017614587 hasConcept C519063684 @default.
• W2017614587 hasConcept C57900726 @default.
• W2017614587 hasConcept C71924100 @default.
• W2017614587 hasConcept C84393581 @default.
• W2017614587 hasConceptScore W2017614587C126322002 @default.
• W2017614587 hasConceptScore W2017614587C164705383 @default.
• W2017614587 hasConceptScore W2017614587C178853913 @default.
• W2017614587 hasConceptScore W2017614587C2777097880 @default.
• W2017614587 hasConceptScore W2017614587C2777953023 @default.
• W2017614587 hasConceptScore W2017614587C2779066535 @default.
• W2017614587 hasConceptScore W2017614587C519063684 @default.
• W2017614587 hasConceptScore W2017614587C57900726 @default.
• W2017614587 hasConceptScore W2017614587C71924100 @default.
• W2017614587 hasConceptScore W2017614587C84393581 @default.
• W2017614587 hasIssue "6" @default.
• W2017614587 hasLocation W20176145871 @default.
• W2017614587 hasLocation W20176145872 @default.
• W2017614587 hasOpenAccess W2017614587 @default.
• W2017614587 hasPrimaryLocation W20176145871 @default.
• W2017614587 hasRelatedWork W1851179650 @default.
• W2017614587 hasRelatedWork W2050500654 @default.
• W2017614587 hasRelatedWork W2143657289 @default.
• W2017614587 hasRelatedWork W2145503432 @default.
• W2017614587 hasRelatedWork W2366943995 @default.
• W2017614587 hasRelatedWork W2367045735 @default.
• W2017614587 hasRelatedWork W2383871815 @default.
• W2017614587 hasRelatedWork W2389089920 @default.
• W2017614587 hasRelatedWork W3009892410 @default.
• W2017614587 hasRelatedWork W3149438219 @default.
• W2017614587 hasVolume "24" @default.
• W2017614587 isParatext "false" @default.
• W2017614587 isRetracted "false" @default.

• next